IRIS
DE MARCHI, Fabiola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.607
NA - Nord America 878
AS - Asia 334
SA - Sud America 7
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.830
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 858
IE - Irlanda 618
IT - Italia 336
SE - Svezia 222
DE - Germania 187
SG - Singapore 146
UA - Ucraina 77
HK - Hong Kong 72
CN - Cina 48
FR - Francia 35
FI - Finlandia 27
IR - Iran 20
CZ - Repubblica Ceca 19
NL - Olanda 19
CA - Canada 18
GB - Regno Unito 17
IN - India 17
TR - Turchia 13
PL - Polonia 12
DK - Danimarca 11
RO - Romania 9
BR - Brasile 7
JP - Giappone 6
BE - Belgio 4
CH - Svizzera 4
ES - Italia 4
VN - Vietnam 4
JO - Giordania 2
PA - Panama 2
PH - Filippine 2
RS - Serbia 2
AT - Austria 1
AU - Australia 1
EG - Egitto 1
EU - Europa 1
GR - Grecia 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
NG - Nigeria 1
PK - Pakistan 1
RU - Federazione Russa 1
TH - Thailandia 1
Totale 2.830
Salva come PNG Salva come JPEG
Città #
Dublin 614
Jacksonville 140
Singapore 97
Hong Kong 70
Chandler 67
Dearborn 58
Mülheim 44
Lawrence 35
Princeton 35
Turin 35
Boardman 34
Wilmington 32
Munich 25
Bremen 24
Strasbourg 24
Beijing 22
Milan 22
San Mateo 17
Dallas 16
Brno 15
Helsinki 15
Rome 15
Piemonte 14
Novara 13
Vercelli 12
Zanjan 12
Seattle 11
Amsterdam 10
Ashburn 10
Monmouth Junction 10
Toronto 10
Kocmyrzów 9
Frankfurt am Main 8
Kocaeli 8
Borgomanero 7
Houston 7
Ann Arbor 6
Cassano Magnago 6
Santa Clara 6
Ardabil 5
Espoo 5
Radauti 5
Sannomaru 5
Brussels 4
Cologne 4
Dong Ket 4
Hefei 4
Menlo Park 4
Nanjing 4
São Paulo 4
Trieste 4
Winchester 4
Zurich 4
Brescia 3
Cambridge 3
Fairfield 3
Foglizzo 3
Gainesville 3
Guarulhos 3
Leawood 3
London 3
Ottawa 3
Pavia 3
Reggio Emilia 3
Rimini 3
San Benedetto del Tronto 3
Stanmore 3
Woodbridge 3
Alanís 2
Almere Stad 2
Amman 2
Andover 2
Ankara 2
Augusta 2
Barcelona 2
Belgrade 2
Cattolica 2
Davoli 2
Erding 2
Flushing 2
Guangzhou 2
Honolulu 2
Jinan 2
Lissone 2
Los Angeles 2
Manila 2
Monza 2
New York 2
Norwalk 2
Odalengo Grande 2
Orbetello 2
Palermo 2
Pardubice 2
Phoenix 2
Prague 2
Prévost 2
Rozzano 2
Sacramento 2
Salerno 2
San Francisco 2
Totale 1.784
Salva come PNG Salva come JPEG
Nome #
Acetyl-L-carnitine and Amyotrophic Lateral Sclerosis: current evidence and potential use. 139
Analysis of the GCG Repeat Length in NIPA1 Gene in C9orf72-mediated ALS in a Large Italian ALS Cohort 84
Advances in stem cell therapy for amyotrophic lateral sclerosis 83
ALS Phenotype Is Influenced by Age, Sex, and Genetics: A Population-Based Study 76
A case of late-onset OCD developing PLS and FTD 70
Characterization of the c9orf72 GC-rich low complexity sequence in two cohorts of Italian and Turkish ALS cases 68
A case of marchiafava bignami disease with frontal cortex involvement and late onset, long-lasting psychiatric symptoms 67
A case of Progressive Non-Fluent Aphasia as onset of Amyotrophic Lateral Sclerosis with FrontoTemporal Dementia 67
Ptosis and bulbar onset: an unusual phenotype of familial ALS? 61
The length of SNCA Rep1 microsatellite may influence cognitive evolution in Parkinson’s disease 60
Chronic obstructive pulmonary disease may complicate Alzheimer's disease: a comorbidity problem 58
Potential Role of Gut Microbiota in ALS Pathogenesis and Possible Novel Therapeutic Strategies 58
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 56
Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials? 55
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial 54
Frontotemporal Dementia Presenting as Gambling Disorder: When a Psychiatric Condition Is the Clue to a Neurodegenerative Disease 51
Headache in immigrant patients: similarities and differences with Italian population 51
Expanding the genetic spectrum of primary familial brain calcification due to SLC2OA2 mutations: a case series 50
Depression and risk of Cognitive Dysfunctions in Amyotrophic Lateral Sclerosis 47
Detection of white matter ultrastructural changes for amyotrophic lateral sclerosis characterization: A diagnostic study from DTI-derived data 47
Marchiafava-Bignami Disease with frontal cortex involvement and late onset, long-lasting psychiatric symptoms: A case report 46
Functional status and oral health in patients with amyotrophic lateral sclerosis: A cross-sectional study 45
Occipital Neuralgia in Chiari I Malformation: Two Different Events or Two Different Faces of the Same Event? 44
A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis 44
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study 44
Predicting Cognitive Decline in Parkinson's Disease: Can We Ask the Genes? 43
Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson's patients 43
Study protocol on the safety and feasibility of a normocaloric ketogenic diet in people with amyotrophic lateral sclerosis 43
Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19 42
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: A population-based study 40
The Potential Role of Peripheral Oxidative Stress on the Neurovascular Unit in Amyotrophic Lateral Sclerosis Pathogenesis: A Preliminary Report from Human and In Vitro Evaluations 40
The prevention of falls in patients with Parkinson's disease with in-home monitoring using a wearable system: a pilot study protocol 39
Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome 37
Neurological emergency at the COVID-19 pandemic: report from a referral hospital in Eastern Piedmont, Italy 37
The Role of Tau beyond Alzheimer’s Disease: A Narrative Review 37
Telehealth in neurodegenerative diseases: Opportunities and challenges for patients and physicians 36
C9ORF72 Repeat Expansion Affects the Proteome of Primary Skin Fibroblasts in ALS 35
Telehealth Approach For Amyotrophic Lateral Sclerosis Patients: The experience during COVID-19 pandemic 33
A pilot trial of RNS60 in amyotrophic lateral sclerosis 32
Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants 29
Accelerated early progression of amyotrophic lateral sclerosis over the covid-19 pandemic 28
Adopting Assistive Technologies in Healthcare Processes: A Chatbot for Patients with Amyotrophic Lateral Sclerosis 27
Characterization of the p.L145F and p.S135N Mutations in SOD1: Impact on the Metabolism of Fibroblasts Derived from Amyotrophic Lateral Sclerosis Patients 26
Rapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial) 26
Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers 25
Critical illness neuro-myopathy (CINM) and focal amyotrophy in intensive care unit (ICU) patients with SARS-CoV-2: a case series 23
Exploring the phenotype of Italian patients with ALS with intermediate ATXN2 polyQ repeats 23
Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study 22
A Telehealth Intervention for Nutritional Counseling in Amyotrophic Lateral Sclerosis Patients 22
Clinical and Metabolic Signature of UNC13A rs12608932 Variant in Amyotrophic Lateral Sclerosis 21
A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine 21
Factors associated with the severity of COVID-19 outcomes in people with neuromuscular diseases: Data from the International Neuromuscular COVID-19 Registry 20
Adjusted cost analysis of video televisits for the care of people with amyotrophic lateral sclerosis 19
The Need for Biomarkers in the ALS-FTD Spectrum: A Clinical Point of View on the Role of Proteomics 19
Gastrointestinal Status and Microbiota Shaping in Amyotrophic Lateral Sclerosis: A New Frontier for Targeting? 19
Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses 18
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact 18
Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort 18
Plateaus in amyotrophic lateral sclerosis progression: results from a population-based cohort 17
Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents 17
Generation of an induced pluripotent stem cell line, CSSi011-A (6534), from an Amyotrophic lateral sclerosis patient with heterozygous L145F mutation in SOD1 gene 17
Cognitive dysfunction in amyotrophic lateral sclerosis: can we predict it? 17
From Biomarkers to Precision Medicine in Neurodegenerative Diseases: Where Are We? 16
Clinical trials in pediatric ALS: a TRICALS feasibility study 15
Patient reported outcomes in ALS: characteristics of the self-entry ALS Functional Rating Scale-revised and the Activities-specific Balance Confidence Scale 15
Respiratory support in a population-based ALS cohort: Demographic, timing and survival determinants 15
Amyotrophic lateral sclerosis regional progression intervals change according to time of involvement of different body regions 15
Patient reported outcome measures (PROMs) in amyotrophic lateral sclerosis 15
New Insights into the Relationship between Nutrition and Neuroinflammation in Alzheimer's Disease: Preventive and Therapeutic Perspectives 15
Exposure to electromagnetic fields does not modify neither the age of onset nor the disease progression in ALS patients 15
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology 15
null 15
Potential role of vitamin D levels in amyotrophic lateral sclerosis cognitive impairment 15
Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and Prognosis 14
What is amyotrophic lateral sclerosis prevalence? 14
Validation of the DYALS (dysphagia in amyotrophic lateral sclerosis) questionnaire for the evaluation of dysphagia in ALS patients 13
Shotgun Proteomics Links Proteoglycan-4+ Extracellular Vesicles to Cognitive Protection in Amyotrophic Lateral Sclerosis 13
Reply to: Amyotrophic lateral sclerosis with depression, cognitive impairment, and mortality 13
The NEALS primary lateral sclerosis registry 13
Do ecological factors influence the clinical presentation of amyotrophic lateral sclerosis? 13
Tailoring patients' enrollment in ALS clinical trials: the effect of disease duration and vital capacity cutoffs 13
Factors predicting disease progression in C9ORF72 ALS patients 12
Cell therapy in ALS: An update on preclinical and clinical studies 11
Effect of mesenchymal stromal cell transplantation on long-term survival in amyotrophic lateral sclerosis 11
Effects of Acetyl-L-Carnitine on Oxidative Stress in Amyotrophic Lateral Sclerosis Patients: Evaluation on Plasma Markers and Members of the Neurovascular Unit 11
Exploring the use of educational materials for increasing participation in a stretching program: a quality improvement project in people with motor neuron disease 11
Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder 10
Integration of a palliative care specialist in an amyotrophic lateral sclerosis clinic: Observations from one center 9
Investigating the Prognostic Role of Peripheral Inflammatory Markers in Mild Cognitive Impairment 8
iPSC-based research in ALS precision medicine 8
Withdrawal of mechanical ventilation in amyotrophic lateral sclerosis patients: a multicenter Italian survey 6
From Mild Cognitive Impairment to Dementia: The Impact of Comorbid Conditions on Disease Conversion 6
Editorial: What's next? Innovative translational markers across the ALS-FTD continuum 6
The diagnostic and prognostic role of biomarkers for amyotrophic lateral sclerosis 6
Novel Therapeutic Strategies in Alzheimer's Disease: Pitfalls and Challenges of Anti-Amyloid Therapies and Beyond 5
Retrospective observational study on the use of acetyl-L-carnitine in ALS 5
Variability in Clinical Phenotype in TARDBP Mutations: Amyotrophic Lateral Sclerosis Case Description and Literature Review 5
The role of peripheral immunity in ALS: a population‐based study 4
Current status and new avenues of stem cell-based preclinical and therapeutic approaches in amyotrophic lateral sclerosis 4
Presymptomatic geographical distribution of ALS patients suggests the involvement of environmental factors in the disease pathogenesis 4
Totale 2.968
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.169
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.169
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020219 0 0 0 0 37 33 51 11 25 34 28 0
2020/2021245 24 2 22 2 41 14 48 9 32 9 34 8
2021/2022304 20 11 15 26 16 7 2 7 23 16 73 88
2022/20231.230 45 56 40 10 82 88 46 54 667 17 98 27
2023/2024571 50 38 80 29 82 20 76 5 13 5 50 123
2024/2025267 45 38 125 36 23 0 0 0 0 0 0 0
Totale 2.988